PhotoPharmics Announces Board Expansion to Support Growth: Clinical, Commercialization and Strategic Partnerships
SALT LAKE CITY, UT, UNITED STATES, December 4, 2025 /EINPresswire.com/ -- PhotoPharmics, a clinical-stage medical device company developing photo-neuromodulation therapies for neurodegenerative diseases today announced the addition of two widely …